Adalimumab-aaty was first approved by the Food and Drug Administration on May 23, 2023 and became commercially available among key distributors across the U.S. on July 2, 2023 Adalimumab-aaty’s …
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66baab89d6de4f73948150968d243c0f&url=https%3A%2F%2Fwww.msn.com%2Fen-ph%2Fhealth%2Fother%2Fcelltrion-usa-announces-incorporation-of-adalimumab-aaty-a-humira-biosimilar-to-the-costco-member-prescription-program%2Far-AA1oGxhU&c=8676854900386646327&mkt=en-us
Author :
Publish date : 2024-08-12 13:06:50
Copyright for syndicated content belongs to the linked Source.